Patient Guide: A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 37 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06465329
Status: 🟢 Enrolling Now
Condition: Non-Small Cell Lung Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 37 locations across the country.

Top locations include:
  • • Orange, California
  • • Skokie, Illinois
  • • Watertown, Massachusetts
  • • And 34 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) - Join Clinical Trial NCTNCT06465329

How to Join This Clinical Trial - NCTNCT06465329

Learn how to participate in this PHASE2 trial studying an investigational therapy for Non-Small Cell Lung Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Small Cell Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Small Cell Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06465329 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 37 locations. Find a study site near you:

Clinical Research Site

Orange, California 92868 - United States

Status: RECRUITING

Clinical Research Site

Skokie, Illinois 60077 - United States

Status: RECRUITING

Clinical Research Site

Watertown, Massachusetts 57201 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: RECRUITING

Clinical Research Site

Farmington Hills, Michigan 48334 - United States

Status: RECRUITING

Clinical Research Site

Morristown, New Jersey 07960 - United States

Status: RECRUITING

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: RECRUITING

Clinical Research Site

Portland, Oregon 97213 - United States

Status: RECRUITING

Clinical Research Site

Providence, Rhode Island 02903 - United States

Status: RECRUITING

Clinical Research Site

Knoxville, Tennessee 37920 - United States

Status: RECRUITING

And 27 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Non-Small Cell Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships